Table 4.
Blood perfusion and its corresponding change magnitude in measurement sites of both meridians in the heart meridian intervention group (mean ± SEM, PU).
| Premoxibustion phase | During 15 min moxibustion | 5 min postmoxibustion phase | |||
|---|---|---|---|---|---|
| Phase A | Phase B | Phase C | |||
| The midpoint between HT3 and HT7 | 8.39 ± 0.28 | 8.95 ± 0.33∗ | 9.24 ± 0.36∗∗ | 9.31 ± 0.33∗∗ | 9.11 ± 0.33∗ |
| — | (0.56 ± 0.15)††## | (0.85 ± 0.16)††## | (0.92 ± 0.16)††## | (0.71 ± 0.17)††## | |
| LU5 of the lung meridian | 10.49 ± 0.39 | 10.37 ± 0.39 | 10.30 ± 0.41 | 10.31 ± 0.40 | 10.33 ± 0.39 |
| — | (−0.12 ± 0.04) | (−0.19 ± 0.07) | (−0.18 ± 0.07) | (−0.16 ± 0.04) | |
| The midpoint between LU5 and LU9 | 9.20 ± 0.32 | 8.89 ± 0.29∗ | 8.88 ± 0.31∗ | 8.82 ± 0.30∗ | 8.80 ± 0.33∗∗ |
| — | (−0.31 ± 0.08) | (−0.32 ± 0.09) | (−0.39 ± 0.09) | (−0.41 ± 0.07) | |
(i) PU: perfusion units. The values in parentheses were the increase (or decrease) values of PU compared to premoxibustion; (ii) ∗∗p < 0.001 and ∗p < 0.01, compared with premoxibustion PU; (iii) ††p < 0.001, compared with LU5; ##p < 0.001, compared with the midpoint between LU5 and LU9.